Direct molecular testing for isoniazid and rifampicin resistance from respiratory specimens of patients with tuberculosis
Carolin Kreiter(Evangelische Lungenklinik Berlin), Torsten Bauer(Helios Klinikum Emil von Behring), Nicolas Schönfeld(Helios Klinikum Emil von Behring), Ralf Otto-Knapp, Anna Streubel(Helios Klinikum Emil von Behring), Torsten Blum(MSB Medical School Berlin), Holger Rüssmann(Helios Klinikum Emil von Behring), Andreas Röth(Helios Klinikum Emil von Behring), Harald Mauch(Helios Klinikum Emil von Behring), Lena Bös(German Central Institute for Social Issues)
Unknown
September 1, 2013
Cited by 0
Related Papers
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
|The Lancet Respiratory Medicine|2021|523
MultiLoc: prediction of protein subcellular localization using N-terminal targeting sequences, sequence motifs and amino acid composition
|Bioinformatics|2006|331
MultiLoc2: integrating phylogeny and Gene Ontology terms improves subcellular protein localization prediction
|BMC Bioinformatics|2009|316
Fatal Outcome in Acute Pancreatitis: Its Occurrence and Early Prediction
|Pancreatology|2001|169
Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms
|Pneumologie|2010|166